Legislators
Bills
Statements
Lobbying
Travel
Searching...- Lobbying
- Lobbying by Antimicrobial Innovation Alliance
Lobbying Relationship
Bills mentioned
H.R.2430: FDA Reauthorization Act of 2017
Sponsor: Greg Walden (R-Ore.)
S.934: FDA Reauthorization Act of 2017
Sponsor: Lamar Alexander (R-Tenn.)
H.R.512: DISARM Act of 2015
Sponsor: Peter Roskam (R-Ill.)
H.R.6: 21st Century Cures Act
Sponsor: Fred Upton (R-Mich.)
H.R.2029: Consolidated Appropriations Act, 2016
Sponsor: Charlie Dent (R-Pa.)
H.R.6294: REVAMP Act
Sponsor: John Shimkus (R-Ill.)
S.2852: Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018
Sponsor: Richard M. Burr (R-N.C.)
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
| Lobbyist | Covered positions? |
|---|---|
| Barrett Thornhill | LA, Sen. Crapo & Rep. Toomey; LA & Press Sec. Rep. Norwood |
| John McManus | Staff Director W&M; LA, Rep. Bill Thomas |
| Chase Thomas | n/a |
| Paul Cronan | n/a |
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate